Correlation Between UroGen Pharma and Sino Biopharmaceutica

Can any of the company-specific risk be diversified away by investing in both UroGen Pharma and Sino Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UroGen Pharma and Sino Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between UroGen Pharma and Sino Biopharmaceutical Limited, you can compare the effects of market volatilities on UroGen Pharma and Sino Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UroGen Pharma with a short position of Sino Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of UroGen Pharma and Sino Biopharmaceutica.

Diversification Opportunities for UroGen Pharma and Sino Biopharmaceutica

0.0

Correlation Coefficient

UroGen Pharma  Sino Biopharmaceutica

Pay attention - limited upside

The 3 months correlation between UroGen and Sino is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding UroGen Pharma and Sino Biopharmaceutical Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sino Biopharmaceutical and UroGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UroGen Pharma are associated (or correlated) with Sino Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sino Biopharmaceutical has no effect on the direction of UroGen Pharma i.e., UroGen Pharma and Sino Biopharmaceutica go up and down completely randomly.

Pair Corralation between UroGen Pharma and Sino Biopharmaceutica

Given the investment horizon of 90 days UroGen Pharma is expected to generate 1.26 times less return on investment than Sino Biopharmaceutica. In addition to that, UroGen Pharma is 1.24 times more volatile than Sino Biopharmaceutical Limited. It trades about 0.05 of its total potential returns per unit of risk. Sino Biopharmaceutical Limited is currently generating about 0.08 per unit of volatility. If you would invest  41.00  in Sino Biopharmaceutical Limited on December 28, 2024 and sell it today you would earn a total of  4.00  from holding Sino Biopharmaceutical Limited or generate 9.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	98.36%
Values	Daily Returns

UroGen Pharma  vs.  Sino Biopharmaceutical Limited

UroGen Pharma

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in UroGen Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating technical and fundamental indicators, UroGen Pharma may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Sino Biopharmaceutical

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sino Biopharmaceutical Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating technical and fundamental indicators, Sino Biopharmaceutica may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with UroGen Pharma and Sino Biopharmaceutica

The main advantage of trading using opposite UroGen Pharma and Sino Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UroGen Pharma position performs unexpectedly, Sino Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sino Biopharmaceutica will offset losses from the drop in Sino Biopharmaceutica's long position.

The idea behind UroGen Pharma and Sino Biopharmaceutical Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.